For example, if you injected medication into your left thigh this morning, use your right thigh this afternoon, your left abdomen tomorrow morning, and your right abdomen tomorrow afternoon
According to a commenter, even if CMS moved to market-based weights, it would still need cost data for other purposes (outlier payments, new technology add-on payments, etc.) and thus, hospitals would shoulder additional reporting duties rather than any offsetting reduction
It's the silent killer of good research
Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor
The integration approach The most pragmatic approach for many patients may not be "peptides instead of conventional treatment" but rather "peptides alongside conventional treatment." Using KPV to modulate NF-kB while on a biologic, for example, could theoretically enhance the biologic effectiveness or allow dose reduction